Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-11

Clinical Trial Update: Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of pioglitazone on HDL function in adults with Type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Miami | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-11-11